Seegene Multiplex PCR assays
Full panel high multiplex assays to maximize the test efficiency
Seegene’s superior accuracy based on DPO™, TOCE™ and MuDT™ technologies combined with All-in-One Platform is a unique streamlined automation solution that can perform a broad menu of molecular diagnostic tests in the area of infectious diseases. The platform allows molecular diagnostic method to be routinely used within clinically meaningful timeframe to reach therapeutic decision-making. The whole process is CE-IVD marked.
Multiplex-PCR with exceptional performance
- DPO™ Technology is the innovative multiple targets amplification technology that enhances target specificity and minimizes the non-specific amplification commonly occurred in multiplex PCR.
- TOCE™ technology enables to detect and differentiate multiple targets in a single tube and also can provide quantitative result by cyclic-CMTA analysis.
- MUDT™ is the world’s first Real-time PCR technology that provides individual Ct values for multiple targets.
- Seegene’s 3 Ct technology can provide the Ct value of three targets in one channel without compromising sensitivity and specificity. The successful development is based on Seegene’s 20-year expertise and combines 19 different patent technologies, including DPO™, TOCE™, and MuDT™.
- Used algorithms enable semi quantitation of pathogens
- Continuously evolving test panels meet clinical diagnostic needs.
Product is available in the following countries:
Links and documents
Keywordsantibiotic resistance PCR
Aliisa MäkinenProduct Manageraliisa.firstname.lastname@example.org +358 40 518 8198
Tiina SalomäkiSales Manager, Team Leadertiina.email@example.com +358 44 722 5648